Why Facilities Are Choosing New Hologic Affirm Breast Biopsy Guidance Systems

Breast cancer diagnosis often requires tissue sampling to definitively characterize suspicious lesions detected on mammography, ultrasound, or other imaging modalities. While excisional surgical biopsy has historically been the gold standard for definitive diagnosis, minimally invasive stereotactic and ultrasound-guided biopsy procedures have revolutionized breast care over the past two decades. These approaches offer patients faster diagnosis, smaller scars, less tissue trauma, and significantly lower costs compared to surgical biopsies—while maintaining equivalent diagnostic accuracy.

The Hologic Affirm stereotactic breast biopsy guidance system represents the current generation of stereotactic biopsy technology, enabling radiologists and interventional specialists to target lesions with exceptional precision, acquire diagnostic tissue samples efficiently, and complete procedures with minimal patient discomfort. For imaging centers and hospital breast programs seeking to offer comprehensive breast diagnostic services, the Affirm system integrated with a Hologic Selenia Dimensions mammography platform creates a powerful, complete breast imaging solution.

Understanding Stereotactic Breast Biopsy

Stereotactic biopsy is a minimally invasive procedure that uses mammographic imaging coordinates to guide a biopsy needle or probe to a specific breast lesion. The procedure begins with the patient positioned prone on a specialized biopsy table, with the affected breast compressed in a similar manner to routine mammography. The radiologist obtains stereotactic images (two images at slightly different angles) that allow precise three-dimensional localization of the lesion relative to the biopsy needle.

Once the lesion is precisely localized, the radiologist advances the biopsy needle into the lesion and acquires multiple tissue samples. Samples are sent to pathology for definitive histologic diagnosis. The entire procedure typically takes 20-30 minutes, and patients can resume normal activities immediately afterward.

Clinical advantages of stereotactic biopsy include:

• Diagnostic Accuracy: Stereotactic biopsy achieves diagnostic accuracy exceeding 98%, equivalent to surgical excision but with minimal tissue trauma.
• Minimal Invasiveness: Small needle probes (typically 11 to 14 gauge) are used, resulting in minimal tissue disruption and scarring compared to surgical biopsy.
• Patient Comfort: Local anesthesia combined with prone positioning results in excellent patient tolerance with minimal discomfort.
• Rapid Results: Pathology turnaround is typically 2-3 business days, allowing rapid diagnosis and treatment planning.
• Cost Efficiency: Stereotactic biopsy costs substantially less than surgical biopsy (typically 30-50% of surgical biopsy costs), reducing patient out-of-pocket expenses and lowering overall healthcare system costs.
• Lesion Excision Capability: Large-bore vacuum-assisted biopsy can remove some lesions entirely, providing both diagnosis and treatment in a single procedure.

The Hologic Affirm Platform Overview

The Hologic Affirm stereotactic biopsy system integrates seamlessly with the Hologic Selenia Dimensions mammography platform, creating a comprehensive breast imaging and intervention solution. Key features of the Affirm system include:

Integrated Biopsy Table: The Affirm-equipped Selenia Dimensions includes a specialized prone biopsy table that positions patients optimally for both screening/diagnostic mammography and stereotactic biopsy procedures. The table design minimizes patient anxiety and maximizes comfort during extended procedures.

Real-Time Stereotactic Guidance: The system provides real-time stereotactic images during lesion localization and needle advancement, enabling radiologists to visualize needle position relative to the target lesion throughout the procedure. This real-time feedback dramatically improves procedural efficiency and sampling accuracy.

Advanced Needle Positioning System: Motorized needle positioning allows precise three-dimensional advancement and needle angulation, reducing procedural time and improving radiologist control during sampling.

Enhanced Visualization: Digital image processing and workstation tools optimize visualization of lesions relative to breast anatomy, improving targeting precision and reducing sampling error.

Biopsyhistory Management: The system integrates with PACS and RIS platforms, maintaining complete biopsy procedure documentation, imaging records, and pathology results in a unified medical record.

Clinical Applications and Case Examples

The Hologic Affirm system excels in several common clinical scenarios:

Microcalcification Clusters: Suspicious microcalcifications detected on screening mammography are a common indication for biopsy. Stereotactic biopsy provides precise lesion localization and tissue sampling, with diagnostic accuracy exceeding 98%. Benign microcalcifications (often fibroadenomas, fibrocystic changes, or vascular calcifications) can be definitively excluded, sparing patients unnecessary surgical excision.

Architectural Distortions: Subtle architectural distortions (irregular tissue patterns suggesting possible malignancy) can be precisely targeted with stereotactic biopsy, rapidly determining whether the finding represents cancer or a benign architectural anomaly.

Masses in Dense Breast Tissue: In patients with dense breast tissue, mammographic visualization of masses can be challenging. Stereotactic biopsy combined with supplemental ultrasound guidance provides reliable diagnosis.

Prior Biopsy Sites: When prior biopsies warrant re-evaluation or when patients present with new findings near previous biopsy sites, stereotactic biopsy enables precise localization and sampling.

Lesion Excision: Large-bore vacuum-assisted biopsy can remove small benign lesions entirely (papillomas, fibroadenomas, radial scars), providing both diagnosis and definitive treatment in a single procedure—eliminating the need for subsequent surgical excision.

Integration with Selenia Dimensions Mammography

The Affirm biopsy system's seamless integration with Hologic's Selenia Dimensions mammography platform creates workflow efficiencies and clinical advantages:

Single-System Solution: Your facility requires only one major imaging system to deliver comprehensive screening, diagnostic, and interventional breast imaging services. This simplifies staff training, reduces capital investment, and optimizes space efficiency.

Unified Imaging Platform: Lesions detected on screening or diagnostic mammography can proceed directly to biopsy on the same system, minimizing patient waiting times and reducing anxiety associated with additional appointments and system transfers.

Coordinated Image Analysis: Radiologists can review screening/diagnostic mammography data alongside stereotactic biopsy imaging and real-time guidance, enabling confident lesion localization and sampling strategy optimization.

Standardized Workflow: Staff training addresses both screening/diagnostic and interventional workflows on a single platform, improving efficiency and reducing training time for new personnel.

Procedural Efficiency and Throughput

For imaging centers and hospital breast programs, procedural efficiency directly impacts profitability and patient satisfaction. The Hologic Affirm system optimizes efficiency through:

Rapid Lesion Localization: Real-time stereotactic imaging and motorized needle positioning reduce procedural time compared to older systems, enabling higher daily biopsy throughput.

Reduced Patient Waiting: Integrated workflow minimizes patient transfer between systems, reducing preparation time and patient anxiety.

Predictable Procedure Duration: Standardized workflows and reliable technical performance enable accurate scheduling and improved operating room/procedure room utilization.

Training Efficiency: New staff trained on integrated Affirm/Selenia Dimensions systems require less overall training time compared to managing separate systems, reducing onboarding costs and accelerating new staff productivity.

Patient Outcomes and Satisfaction

Beyond operational efficiency, the Affirm system prioritizes patient outcomes and satisfaction:

Diagnostic Certainty: Pathology results from stereotactic biopsy provide definitive diagnosis, enabling confident treatment planning and reducing patient anxiety associated with diagnostic uncertainty.

Treatment Acceleration: Rapid, accurate diagnosis enables faster treatment decision-making and care initiation, improving patient satisfaction and clinical outcomes.

Lesion Excision Option: For appropriate lesions, vacuum-assisted biopsy can remove pathology entirely, providing both diagnosis and treatment in a single procedure.

Minimal Recovery Time: Minimally invasive stereotactic biopsy allows patients to resume normal activities immediately, compared to surgical biopsy's longer recovery period.

Training and Technical Support

ARRAD provides comprehensive training and ongoing support for facilities implementing the Hologic Affirm system:

Radiologist Training: Advanced instruction on stereotactic lesion localization, biopsy needle positioning, sampling strategy, and integration with diagnostic mammography findings. Training emphasizes optimization of procedure efficiency and diagnostic accuracy.

Technologist Training: Hands-on instruction on patient positioning, system operation, image acquisition, procedure workflow, and equipment troubleshooting. Training ensures smooth clinical integration of biopsy procedures into your breast imaging workflow.

Ongoing Support: ARRAD maintains 24/7 technical support for procedure-related questions, equipment troubleshooting, and clinical consultation as your team gains experience with stereotactic biopsy.

Competitive Differentiation and Marketing

Offering on-site stereotactic biopsy capability with the Hologic Affirm system differentiates your facility in a competitive breast imaging marketplace:

• Attracts referring physicians seeking comprehensive breast diagnostic services
• Improves patient satisfaction through convenient, on-site diagnostic and interventional services
• Generates revenue through interventional procedures, supplementing diagnostic imaging income
• Positions your facility as a breast imaging leader, supporting marketing and recruitment efforts

Financing and Implementation

ARRAD works with healthcare facilities to structure Affirm system purchases that fit your financial planning and budget cycles. Options include direct purchase, lease arrangements, equipment trade-in programs, and equipment financing coordinated through specialized medical device financing companies.

Bring Comprehensive Breast Imaging to Your Facility

Ready to integrate stereotactic biopsy capability into your breast imaging program? ARRAD can help you implement a complete Hologic Affirm and Selenia Dimensions breast imaging solution. Contact our team at 877.299.8303, request a quote online, or email info@arrad.net to discuss your facility's needs and explore implementation options.